Comera Life Sciences Holdings, Inc. Aktie - Unternehmensdaten & Kurse - US20037C1080 | MoneyPeak

Comera Life Sciences Holdings, Inc.

Share · US20037C1080 · CMRA (XNAS)

No Price

n/a

Share Float & Liquidity

Free Float 44,01 %

Shares Float 13,53 M

Shares Outstanding 30,74 M

Company Profile for Comera Life Sciences Holdings, Inc. Share

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Company Data

Name Comera Life Sciences Holdings, Inc.

Company Comera Life Sciences Holdings, Inc.

Symbol CMRA

Website https://comeralifesciences.com

Primary Exchange

NASDAQ

ISIN US20037C1080

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Michael G. Campbell CPA

Country United States of America

Currency USD

Employees 0,0 T

Address 12 Gill Street, 01801 Woburn

IPO Date 2020-12-21

Ticker Symbols

Name	Symbol
NASDAQ	CMRA
NASDAQ	CMRAW

More Shares

Investors who hold Comera Life Sciences Holdings, Inc. also have the following shares in their portfolio:

FAR EAST CONS. INTL Share

SEAGEN INC Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025